Literature DB >> 20219876

Beneficial dysregulation of the time course of inflammatory mediators in lipopolysaccharide-induced tumor necrosis factor alpha factor-deficient mice.

Sreedevi Srinivasan1, Susan E Leeman, Salomon Amar.   

Abstract

To begin to understand the surprising survival of macrophage-specific lipopolysaccharide-induced tumor necrosis factor alpha factor-deficient (macLITAF(-/-)) animals after a lethal dose of lipopolysaccharide (LPS), as reported earlier, the present follow-up study focuses on the role of LITAF in the regulation of inflammatory cytokines secreted in response to lethal or sublethal doses of LPS administered to wild-type (WT) and macLITAF(-/-) mice. A time course study of kinase expression in peritoneal macrophages revealed increased phosphorylation of prosurvival kinases Akt, Erk1/2, and ribosomal S6 kinase (RSK) in macLITAF(-/-) mice compared to that in WT mice (n = 8), confirming their role in LPS-mediated diseases. macLITAF(-/-) mice (n = 8) survived a lethal dose of LPS plus d-galactosamine (d-GalN), expressing lower serum levels of pro- and anti-inflammatory cytokines than the WT levels. To extend our knowledge on LPS-induced inflammatory events, an effective sublethal dose of LPS was administered to the animals (n = 14). WT animals exhibited an acute inflammatory response that decreased after 4 h. Interestingly, macLITAF(-/-) mice exhibited an initial delay in the secretion of proinflammatory cytokines that peaked after 8 h and reached WT levels after 18 h. Anti-inflammatory cytokine secretions were initially delayed but increased after 4 h and remained elevated compared to WT levels, even after 18 h. Our results demonstrate that LITAF deficiency in vivo affects cytokines other than TNF-alpha and influences the balance between the pro- and anti-inflammatory cytokines, which protects the animals from the deleterious effects of an LPS-induced inflammatory response, resulting in a beneficial host regulation of inflammatory cytokines and in enhanced survival. Therapeutic intervention aimed at reducing LITAF via kinase modulators may prove useful in preventing LPS-induced mortality.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20219876      PMCID: PMC2863386          DOI: 10.1128/CVI.00510-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  26 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  A permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability.

Authors:  M Clauss; C Sunderkötter; B Sveinbjörnsson; S Hippenstiel; A Willuweit; M Marino; E Haas; R Seljelid; P Scheurich; N Suttorp; M Grell; W Risau
Journal:  Blood       Date:  2001-03-01       Impact factor: 22.113

Review 3.  The biology of cachectin/TNF--a primary mediator of the host response.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

4.  Tumour necrosis factor activity in joint fluids from rheumatoid arthritis patients.

Authors:  M L Neale; B D Williams; N Matthews
Journal:  Br J Rheumatol       Date:  1989-04

5.  Shock and tissue injury induced by recombinant human cachectin.

Authors:  K J Tracey; B Beutler; S F Lowry; J Merryweather; S Wolpe; I W Milsark; R J Hariri; T J Fahey; A Zentella; J D Albert
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

6.  MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol.

Authors:  Aaron M Domina; Julie A Vrana; Mark A Gregory; Stephen R Hann; Ruth W Craig
Journal:  Oncogene       Date:  2004-07-08       Impact factor: 9.867

7.  Acute in vivo effects of human recombinant tumor necrosis factor.

Authors:  D G Remick; R G Kunkel; J W Larrick; S L Kunkel
Journal:  Lab Invest       Date:  1987-06       Impact factor: 5.662

8.  IL-10 inhibits cytokine production by activated macrophages.

Authors:  D F Fiorentino; A Zlotnik; T R Mosmann; M Howard; A O'Garra
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

Review 9.  Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium.

Authors:  S Haider; M Knöfler
Journal:  Placenta       Date:  2008-11-22       Impact factor: 3.481

10.  Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.

Authors:  V Lehmann; M A Freudenberg; C Galanos
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

View more
  11 in total

1.  Whole-body deletion of LPS-induced TNF-α factor (LITAF) markedly improves experimental endotoxic shock and inflammatory arthritis.

Authors:  Jamie C Merrill; Jian You; Cara Constable; Susan E Leeman; Salomon Amar
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  Minocycline ameliorates LPS-induced inflammation in human monocytes by novel mechanisms including LOX-1, Nur77 and LITAF inhibition.

Authors:  Tao Pang; Juan Wang; Julius Benicky; Juan M Saavedra
Journal:  Biochim Biophys Acta       Date:  2012-01-27

3.  Dysregulated Inflammatory Signaling upon Charcot-Marie-Tooth Type 1C Mutation of SIMPLE Protein.

Authors:  Wenjing Li; Hong Zhu; Xuelian Zhao; Deborah Brancho; Yuanxin Liang; Yiyu Zou; Craig Bennett; Chi-Wing Chow
Journal:  Mol Cell Biol       Date:  2015-07       Impact factor: 4.272

4.  Pivotal role of NOD2 in inflammatory processes affecting atherosclerosis and periodontal bone loss.

Authors:  Huaiping Yuan; Sami Zelkha; Sami Zelka; Marina Burkatovskaya; Rohit Gupte; Susan E Leeman; Salomon Amar
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

5.  Bioinformatics analysis of macrophages exposed to Porphyromonas gingivalis: implications in acute vs. chronic infections.

Authors:  Wen-Han Yu; Han Hu; Qingde Zhou; Yu Xia; Salomon Amar
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.240

6.  Age-related alterations in retinal neurovascular and inflammatory transcripts.

Authors:  Colleen A Van Kirk; Heather D VanGuilder; Megan Young; Julie A Farley; William E Sonntag; Willard M Freeman
Journal:  Mol Vis       Date:  2011-05-07       Impact factor: 2.367

7.  The prolyl isomerase Pin1 modulates development of CD8+ cDC in mice.

Authors:  Theresa J Barberi; Alexis Dunkle; You-Wen He; Luigi Racioppi; Anthony R Means
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

8.  Mutation of SIMPLE in Charcot-Marie-Tooth 1C alters production of exosomes.

Authors:  Hong Zhu; Sara Guariglia; Raymond Y L Yu; Wenjing Li; Deborah Brancho; Hector Peinado; David Lyden; James Salzer; Craig Bennett; Chi-Wing Chow
Journal:  Mol Biol Cell       Date:  2013-04-10       Impact factor: 4.138

9.  Gram Negative Bacterial Inflammation Ameliorated by the Plasma Protein Beta 2-Glycoprotein I.

Authors:  Saijun Zhou; Gang Chen; Miao Qi; Fatima El-Assaad; Ying Wang; Shangwen Dong; Liming Chen; Demin Yu; James C Weaver; Julia Beretov; Steven A Krilis; Bill Giannakopoulos
Journal:  Sci Rep       Date:  2016-09-27       Impact factor: 4.379

10.  Increasing Tau 4R Tau Levels Exacerbates Hippocampal Tau Hyperphosphorylation in the hTau Model of Tauopathy but Also Tau Dephosphorylation Following Acute Systemic Inflammation.

Authors:  Matthew R Barron; Jane Gartlon; Lee A Dawson; Peter J Atkinson; Marie-Christine Pardon
Journal:  Front Immunol       Date:  2020-03-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.